Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

计划入组 18 人 · 首次发布于 2020 年 11 月 5 日

Validation of the GATE Software

计划入组 30 人 · 首次发布于 2010 年 12 月 23 日

Glitazones and Endothelial Function (GATE)

计划入组 40 人 · 首次发布于 2005 年 9 月 20 日

GATE-101

GATE-301

GATE-102

Gate Neurosciences, Inc.

United States

AMARA VENTURES

India

Gate City Medical Equipment, Inc.

United States

PATH EX Secures $5 Million to Advance Novel Sepsis Treatment Device CycloPE

Gate Bioscience Partners with Lilly in $856 Million Deal to Develop Novel Molecular Gate Therapeutics

Gate Bioscience Raises $65 Million Series B to Advance Novel Oral Molecular Gate Therapies into Clinical Trials